Entries by Evolution Biotechnologies

Evolution Biotechnologies – Austin, Texas, May 20th 2021

Austin, Texas, May 20th 2021 Evolution Biotechnologies Inc., the Texas-based company extending the use of biological control into medically important areas, today announces the publication of an interview by Phage Directory (https://phage.directory/) in its online news source “Capsid and Tail”, under the title “Phages Before the Phrenzy: Part I — An interview with Dr. David […]

Evolution Biotechnologies – Austin, Texas, February 12th 2021

Austin, Texas, 12th February 2021 Evolution Biotechnologies Inc., the Texas-based company extending the use of biological control into medically important areas, today announces the publication of the book and web resource “Bacteriophages: Biology, Technology, Therapy”, published by Springer. Details are available on line at: https://www.springer.com/gp/book/9783319419855 Edited by three members of the Evolution team, along with […]

Evolution Biotechnologies – Austin, Texas, 13th September 2020

Austin, Texas, 13th September 2020 Evolution Biotechnologies Inc., the company extending the use of biological control into medically important areas, today announced the publication of two chapters on phage therapy written by its CEO, Dr. David R. Harper. Entitled “Introduction to Bacteriophages” and “Intellectual Property Issues for Bacteriophages”, the chapters have been published on line […]

Evolution Biotechnologies – Austin, Texas, 30th August 2020

Austin, Texas, 30th August 2020 Evolution Biotechnologies Inc., the company extending the use of biological control into medically important areas, today announced the publication of a chapter on phage therapy written by its CEO, Dr. David R. Harper. Entitled “Selection of Disease Targets for Phage Therapy”, the chapter has been published on line by Springer […]

Evolution Biotechnologies Austin, Texas, 15th August 2020

Austin, Texas, 15th August 2020 Evolution Biotechnologies Inc., the company extending the use of biological control into medically important areas, today announced the publication of a chapter on phage therapy written by its Senior Consultant, Dr. Ben Burrowes. Entitled “Isolation of Bacteriophages”, the chapter has been published online by Springer Nature, prior to its inclusion […]

Evolution Biotechnologies announces expansion of operations in the United States

Austin, Texas, 17th January 2020 Evolution Biotechnologies the company extending the use of biological control into medically important areas, today announced the opening of Evolution Biotechnologies Inc., of Austin, Texas. The company is focussed on phage therapy, initially targeting the antibiotic resistant superbug Pseudomonas aeruginosa. This will initially target disease in companion animals as a […]